Vanguard Group Inc Merus N.V. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Merus N.V. stock. As of the latest transaction made, Vanguard Group Inc holds 246,934 shares of MRUS stock, worth $9.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

246,934

Previous 164,049 50.52%

Holding current value

$9.79 Million

Previous $9.71 Million 27.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$47.19 - $58.84 $3.91 Million - $4.88 Million	82,885 Added 50.52%	246,934 $12.3 Million
Q2 2024 Aug 13, 2024	BUY	$39.81 - $60.2 $314,499 - $475,580	7,900 Added 5.06%	164,049 $9.71 Million
Q1 2024 May 10, 2024	BUY	$28.03 - $51.82 $117,501 - $217,229	4,192 Added 2.76%	156,149 $7.03 Million
Q4 2023 Feb 14, 2024	SELL	$20.06 - $28.66 $543,485 - $776,485	-27,093 Reduced 15.13%	151,957 $4.18 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $1.13 Million - $1.53 Million	56,043 Added 45.56%	179,050 $4.22 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $23,480 - $34,817	1,281 Added 1.05%	123,007 $3.24 Million
Q4 2022 Feb 10, 2023	SELL	$12.8 - $23.66 $58,112 - $107,416	-4,540 Reduced 3.6%	121,726 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $289,852 - $449,861	15,550 Added 14.04%	126,266 $2.53 Million
Q2 2022 Aug 12, 2022	SELL	$13.98 - $29.25 $142,218 - $297,560	-10,173 Reduced 8.42%	110,716 $2.51 Million
Q1 2022 May 13, 2022	BUY	$23.58 - $30.91 $15,044 - $19,720	638 Added 0.53%	120,889 $3.2 Million
Q4 2021 Feb 14, 2022	SELL	$20.0 - $32.29 $123,700 - $199,713	-6,185 Reduced 4.89%	120,251 $3.82 Million
Q3 2021 Nov 12, 2021	BUY	$16.48 - $27.23 $255,505 - $422,173	15,504 Added 13.98%	126,436 $2.78 Million
Q2 2021 Aug 13, 2021	BUY	$20.0 - $25.48 $2.22 Million - $2.83 Million	110,932 New	110,932 $2.34 Million

Others Institutions Holding MRUS

# of Institutions

203

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.82B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Merus N.V. Transaction History